1.Clinical study of relationship between early neonatal respiratory faster and childhood asthma
Chinese Journal of Primary Medicine and Pharmacy 2017;24(4):586-588
Objective To explore the relationship between early neonatal respiratory faster and asthma in children in the future.Methods 82 cases of unexplained breathing faster after babies born were selected as observa-tion group,and 82 normal newborns at the same period were selected as the control group.The newborns were followed up for 4 -5 years,the incidence of neonatal asthma in the future were compared between the two groups.Results The indicators between observation group and control group had statistically significant differences (all P <0.05).In the observation group,there were 11 cases of clinical diagnosis of infantile asthma,the incidence rate was 13.41%(11 /82),and in the control group,there were 2 cases of clinical diagnosis of infantile asthma,the incidence rate was 2.44%(2 /82).The difference between two groups was statistically significant (χ2 =5.35,P <0.05).Conclusion Early neonatal respiratory faster is closely associated with asthma in children in the future.
2.Efficacy analysis of early intervention in 240 cases with neonatal jaundice
Chinese Journal of Primary Medicine and Pharmacy 2017;24(9):1394-1397
Objective To explore the early intervention time and method for neonatal jaundice,to prevent excessive treatment and delay treatment.Methods From July 2014 to June 2014,240 full term neonates with high bilirubin value were divided into treatment group and observation group.The treatment group was given blue light treatment,the observation group was given general treatment such as intestinal probiotics,Yinzhihuang oral liquid.The treatment time,duration of jaundice of newborn babies,full refund yellow bilirubin value of time and follow-up at the 28th day were observed in two groups.Results In the two groups after treatment,without conversion of blood treatment in 1 case,1 case of bilirubin encephalopathy.In the control group,the treatment tine,the duration of jaundice,jaundice time were (7.84 ± 1.79) d,(10.40 ± 1.30) d,(13.85 ± 1.88) d,which in the treatment group were (4.55 ±1.63)d,(8.70 ± 1.50)d,(1 1.12 ± 1.65)d respectively,there were significant differences between the two groups (t =14.74,9.36,11.70,all P < 0.01).In the control group,the bilirubin level at 28 d follow-up was (13.20 ± 2.47) μ mol/L,that of the treatment group was (12.06 ± 2.53)μ mol/L,there was no significant difference between the two groups(t =3.52,P > 0.05).Conclusion The key of neonatal jaundice treatment is prevent the happening of the bilirubin encephalopathy,as long as jaundice intervention recommendation should be timely intervened.Blue light is the first selection of neonatal jaundice intervention method,treatment effect is exact;Full moon to the health of more than 3 days,total bilirubin blood although has reached the blue-ray standard treatment,on the premise of strict monitoring of bilirubin,can temporarily not blue light.